Insider Transactions Reported by 25 Insiders of CVRx, Inc.

Symbol
CVRX on Nasdaq
Location
Minneapolis, MN

Insiders trading volume in the past year

CVRx, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
JOHNSON & JOHNSON 10%+ Owner $40,529,835 -$637,002 -1.5% 26 Nov 2025
Johnson & Johnson Innovation - JJDC, Inc. 10%+ Owner $13,824,999 15 Sep 2023
Kirk G. Nielsen Director $10,555,670 +$1,037,142 +11% 03 Jun 2025
NEW ENTERPRISE ASSOCIATES 10 L P 10%+ Owner $8,013,158 02 Jul 2021
Geoffrey B. Pardo Director $7,287,156 02 Jul 2021
Mudit K. Jain Director $5,953,629 +$7,775 +0.13% 03 Jun 2025
GSK plc 10%+ Owner $3,984,991 02 Jul 2021
Kevin Hykes PRES & CEO, Director $1,404,588 +$24,200 +1.8% 12 May 2025
Robert Allen John Chief Revenue Officer $942,154 28 Feb 2025
NEA PARTNERS 10 L P 10%+ Owner $685,750 02 Jul 2021
JARED OASHEIM Chief Financial Officer $678,112 28 Feb 2025
Philip B. Adamson Chief Medical Officer $425,792 28 Feb 2025
JOSEPH P. SLATTERY Director $388,317 03 Jun 2025
PAUL VERRASTRO Chief Mktg & Strat Officer $351,971 28 Feb 2025
JOHN M. NEHRA Director $250,918 07 Jun 2022
DEAN BRUHN-DING Vp Of Reg. Affairs And Qa $246,979 02 Aug 2022
Nadim Yared CHIEF EXECUTIVE OFFICER, Director $217,198 02 Feb 2024
Kevin J. Ballinger Director $185,775 03 Jun 2025
Mitch C. Hill Director $185,775 03 Jun 2025
Ali Behbahani Director $141,342 04 Jun 2024
MARTHA SHADAN Director $140,092 03 Jun 2025
JOHN BRINTNALL Chief Strategy Officer And Sec $124,688 22 Apr 2022
Brent Binkowski Chief Operating Officer $114,042 11 Aug 2025
Craig E. Palmer Svp, U.S. Sales $6,318 25 Mar 2024
Liz Galle Vp Of Global Clinical Research $3,077 16 Oct 2023

Recent Insider Transactions by Companies or Individuals for CVRx, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.